Teva Loses Challenge Of €60M Pay-For-Delay Fine
By Matthew Perlman ( October 18, 2023, 7:10 PM EDT) -- A European court on Wednesday rejected an appeal from Teva and its subsidiary Cephalon seeking to nix more than €60 million ($63.2 million) in fines for allegedly conspiring with one another in 2005 to keep a generic version of the sleep disorder drug Provigil off the market....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.